XERIS BIOPHARMA HOLDINGS INC - NOTE 5.000% 7/1

Historical Portfolio Holders from Q2 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / NOTE 5.000% 7/1
Shares, excl. options Q1 2024
14.7 M
Holdings value Q1 2024
$15.1 M
Value change Q1 2024
-$18.6 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
2
Number of buys Q1 2024
1
Number of sells Q1 2024
-1
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
98422LAA5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 14.7 M $15.1 M -$18.6 K $1.03 2
2023 Q4 14.7 M $15.9 M $0 $1.09 3
2023 Q3 14.7 M $14.5 M -$36.8 M $0.98 3
2023 Q2 46.7 M $53.1 M +$481 K $1.10 5
2023 Q1 46.7 M $42.6 M +$71.7 K $0.89 6
2022 Q4 46.4 M $42.7 M +$2.17 M $0.84 5
2022 Q3 46.7 M $43.9 M $0 $0.93 5
2022 Q2 46.7 M $43.3 M $0 $0.91 5
2022 Q1 46.7 M $54.6 M $0 $1.17 5
2021 Q4 46.7 M $56.9 M $0 $1.24 5
2021 Q3 46.7 M $51.9 M +$22.4 K $1.14 5
2021 Q2 46.7 M $73.7 M +$13.1 K $1.57 5
2021 Q1 46.7 M $79.1 M +$1.54 M $1.70 5
2020 Q4 43.7 M $76.6 M -$68.4 M $1.76 6
2020 Q3 83.1 M $163 M +$17.8 M $1.94 15
2020 Q2 81 M $80.5 M +$80.5 M $0.99 21